个人简历
中国科学院杭州医学研究所特聘研究员,先后在美国佛罗里达大学和美国宾夕法尼亚州立大学从事科研工作。罗华程课题组致力于探索表观遗传修饰分子图谱调控恶性肿瘤发生发展分子机制以及在肿瘤治疗中的应用前景,主要研究方向包括:1). 探索功能核酸靶向METTL3甲基化酶在恶性肿瘤发生和治疗中的表观调控机制;2). 阐明长链非编码RNA介导染色质三维结构在造血系统和白血病发生中的分子机理;3). m6A甲基化修饰蛋白介导R-Loop结构在肿瘤发生中的功能机制。 相关研究成果以第一或通讯作者发表在Leukemia (2023), Molecular Cell (2022, 封面文章), Cancer Cell (2019, 封面文章), Blood (2018, 封面文章), Science Advances (2020), Nature Communications (2021), Oncogene (2022), Advanced Science (2021) 等国际权威期刊。曾获得美国白血病基金会和国家癌症研究所的科研资助。目前主持国家自然科学基金面上项目2项和主持浙江省自然科学基金重大项目1项。
中国科学院杭州医学研究所特聘研究员,先后在美国佛罗里达大学和美国宾夕法尼亚州立大学从事科研工作。罗华程课题组致力于探索表观遗传修饰分子图谱调控恶性肿瘤发生发展分子机制以及在肿瘤治疗中的应用前景,主要研究方向包括:1). 探索功能核酸靶向METTL3甲基化酶在恶性肿瘤发生和治疗中的表观调控机制;2). 阐明长链非编码RNA介导染色质三维结构在造血系统和白血病发生中的分子机理;3). m6A甲基化修饰蛋白介导R-Loop结构在肿瘤发生中的功能机制。 相关研究成果以第一或通讯作者发表在Leukemia (2023), Molecular Cell (2022, 封面文章), Cancer Cell (2019, 封面文章), Blood (2018, 封面文章), Science Advances (2020), Nature Communications (2021), Oncogene (2022), Advanced Science (2021) 等国际权威期刊。曾获得美国白血病基金会和国家癌症研究所的科研资助。目前主持国家自然科学基金面上项目2项和主持浙江省自然科学基金重大项目1项。
代表论著
1.Qian Lai*, Karina Hamamoto*, Huacheng Luo*(共一), Julia Lesperance, Jie Zha, Yi Qiu, Olga Guryanova, Suming Huang, and Bing Xu. NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology. Leukemia. (2023).37(8):1732-1736. (影响因子: 12.883)
2.Huacheng Luo, Ganqian Zhu, Melanie Eshelman, Xiaoyan Ma, Qian Lai, Nicholas Cesari, Shi Chen, Christopher Cogle, Ruben Mesa, Sinisa Dovat, Chi Wai Eric So, Feng-Chun Yang, Yi Qiu, Mingjiang Xu, and Suming Huang. HOTTIP dependent R-loop formation regulates CTCF boundary and TAD integrity in acute myeloid leukemia. Molecular Cell. (2022), 82(4): 833–851.(影响因子: 19.328) (封面文章)
3.Ajeet Singh*, Huacheng Luo*,#(共一和通讯作者), Meghana Matur, Melanie Eshelman, Karina Hamamoto, Arati Sharma, Julia Lesperance, Suming Huang. A coordinated function of lncRNA HOTTIP and miRNA-196b underpinning leukemogenesis by targeting Fas signaling. Oncogene. (2022), 41, 718–731. (影响因子: 9.867)
4.Ganqian Zhu*, Huacheng Luo* (共一), Yang Feng, Olga A. Guryanova, Jianfeng Xu, Shi Chen, Qian Lai, Arati Sharma, Bing Xu, Zhigang Zhao, Ru Feng, Hongyu Ni, David Claxton, Ying Guo, Ruben A. Mesa, Yi Qiu, Feng-Chun Yang, Wei Li, Stephen D. Nimer, Suming Huang and Mingjiang Xu. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Nature Communications. (2021), 12(1):1956. (影响因子: 17.694).
5.Huacheng Luo, Qin Yu, Yang Liu, Ming Tang, Mingwei Liang, Dingpeng Zhang, Tsan Sam Xiao, Lizi Wu, Ming Tan, Yijun Ruan, Jörg Bungert, Jianrong Lu. LATS kinase-mediated CTCF phosphorylation and selective loss of genomic binding. Science Advances. (2020). Vol. 6, no. 8, eaaw4651. DOI: 10.1126/sciadv.aaw4651. (影响因子: 14.957)
6.Huacheng Luo, Ganqian Zhu, Jianfeng Xu, Qian Lai, Bowen Yan, Ying Guo, Tsz Kan Fung, Bernd B. Zeisig, Ya Cui, Jie Zha, Christopher Cogle, Fei Wang, Bing Xu, Feng-Chun Yang, Wei Li, Chi Wai Eric So, Yi Qiu, Mingjiang Xu, and Suming Huang. HOTTIP lncRNA promotes hematopoietic stem cell self-renewal leading to AML-like disease in mice. Cancer Cell. (2019). pii: S1535-6108(19)30485-4) (影响因子: 50.3)(封面文章)
7.Huacheng Luo, Fei Wang, Jie Zha, Haoli Li, Bowen Yan, Qinghua Du, Fengchun Yang, Amin Sobh, Christopher Vulpe, Leylah Drusbosky, Christopher Cogle , Iouri Chepelev , Bing Xu , Stephen D. Nimer , Jonathan Licht, Yi Qiu,Baoan Chen, Mingjiang Xu, and Suming Huang. CTCF boundary remodels chromatin domain and drives aberrant HOX gene transcription in acute myeloid leukemia. Blood. (2018), 132(8):837-848. (影响因子: 25.476) (封面文章)
8.Yiju Wei*, Huacheng Luo* (共一), Patricia P. Yee, Lijun Zhang, Zhijun Liu, Haiyan Zheng, Lei Zhang, Benjamin Anderson, Suming Huang and Wei Li. Paraspeckle Protein NONO Promotes TAZ Phase Separation in the Nucleus to Drive the Oncogenic Transcriptional Program. Advanced Science. (2021), 8(24):e2102653. (影响因子: 17.521)
9.Huacheng Luo, Anitha K Shenoy, Xuehui Li, Yue Jin, Lihua Jin, Qingsong Cai, Ming Tang, David Reisman, Lizi Wu, Yi Qiu, Yali Dou, Robert Casero, Yang Liu, Jianrong Lu. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition. Cell Reports. (2016).15(12), 2665–2678. (影响因子: 9.995)